FDG-PET Directed Treatment in Improving Response in Patients With Locally Advanced Stomach or Gastroesophageal Junction Cancer

NCT02485834 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

5

Enrollment

OTHER

Sponsor class

Stopped Poor accrual

Conditions

Adenocarcinoma of the Gastroesophageal Junction
Gastric Adenocarcinoma
Gastric Cancer

Interventions

PROCEDURE: FDG-PET
PROCEDURE: surgery
DRUG: 5-FU
DRUG: capecitabine
DRUG: docetaxel
DRUG: Irinotecan
RADIATION: 3D-CRT
RADIATION: IMRT

Sponsor

Alliance for Clinical Trials in Oncology

Collaborators

[object Object]